For Institutions
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Careers
Contact Us
English
日本語
简体中文
Menu
For Institutions
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Careers
Contact Us
English
日本語
简体中文
For Institutions
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Careers
Contact Us
English
日本語
简体中文
Menu
For Institutions
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Careers
Contact Us
English
日本語
简体中文
Twitter
Facebook-f
News
All
Press
Media
Events
Other
I Peace in the News – the Nikkei March 22, 2021
•
March 22, 2021
•
Media
[Summary of Research]Autologous transplantation of iPS cell-derived dopaminergic neurons alleviates motor and depressive behaviors in Parkinson’s model monkeys
•
March 19, 2021
•
Other
[Summary of Research]The University of Arizona developed a human iPS cell-derived cardiomyocyte patch for the treatment of heart failure (Published in 2019)
•
March 12, 2021
•
Other
[Summary of Research]Kyoto University has generated iPS cells with less risk of rejection by genome editing
•
March 2, 2021
•
Other
I Peace CEO Tanabe pressents at RINK FESTIVAL 2021
•
February 25, 2021
•
Events
[Summary of Research]Kyoto University has succeeded in regenerating T-cells from human iPS cells that enhance effects of cancer immunotherapy(2018)
•
February 22, 2021
•
Other
[Summary of research available] Kyoto University developed a scalable method to regenerate T-cells from iPSCs
•
February 5, 2021
•
Other
Renewal of I Peace website
•
February 5, 2021
•
Other
I Peace in the News – the NIKKAN KOGYO SHIMBUN December 28, 2020
•
January 10, 2021
•
Media
I Peace, Inc. and Avery Therapeutics announce collaboration to bring iPSC derived cell therapy for heart failure to the clinic
•
December 29, 2020
•
Press
Reach out to us to learn more
Contact Us